As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
Bigg Boss 19's Tanya Mittal clarifies she never claimed 150 bodyguards, gives a tour of her pharma factory, and reveals an acting offer from Ekta Kapoor. Read her full statement.
Discover how Ayurveda is bridging the gap in breast cancer care, complementing Western treatments to manage side effects and improve patient quality of life. Learn about the integrated approach.
Wall Street's major indexes fell slightly on the last trading day of 2025 but are set for strong double-digit yearly gains, fueled by AI stocks. Nike and Vanda Pharma saw notable moves.
Meta acquires Singapore-based AI startup Manus to boost its AI capabilities. Learn about the deal's details, Manus's technology, and what it means for the future of AI.
Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak has published results for B.Pharmacy, GNM, and M.Pharma exams. Download official gazettes from uhsr.ac.in.
Varanasi and Mirzapur police crack down on a major codeine-based cough syrup smuggling ring, arresting six. The network used shell firms and hawala to supply syrup to Bangladesh at 10x price.
Telangana police arrest Sigachi MD Amit Raj Sinha for negligence in June 30 blast that killed 54 workers. Case highlights safety failures in hazardous units. Read the full investigation details.
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
Indian IT major Coforge announces a landmark $2.35 billion acquisition of US-based AI firm Encora, reshaping its global AI capabilities. Read the full details.
Ajanta Pharma partners with Biocon to market weight-loss drug semaglutide in 26 markets. Deal expected to add ₹200 crore sales by FY28, enhancing its branded generics focus. Read more.
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
The Greater Mohali Area Development Authority has successfully acquired 716 acres of land from nine villages for its ambitious Eco City 3 project, paving the way for a new integrated township.
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
Ajanta Pharma partners with Biocon to distribute generic semaglutide in 26 Asian and African markets. The move targets the booming GLP-1 market post-patent expiry, leveraging Ajanta's strong distribution network.
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
A Moradabad land acquisition court has ordered the attachment of the Bijnor DM's official residence for failing to pay Rs 25.2 lakh compensation to a landowner since 2020. Read the full story.
UST and IIT Madras Incubation Cell sign MoU to accelerate healthcare startups. 'Pitch to Win: Pharma 4.0' challenge sees 90+ entries. Winners get funding up to Rs 45 lakh. Read more.
CGST Rohtak arrests Sonipat pharma trader Pawel Garg for alleged GST evasion of Rs 21.30 crore on sales of Rs 118.49 crore. Raid uncovers unaccounted transactions. Read the full details.
National Award-winning actor Rajit Kapur discusses his return to Malayalam cinema with the medical drama 'Pharma', his role as Dr. Rajiv Rao, and the rise of South Indian OTT content.
A multibagger stock under Rs 100 makes a strategic move by acquiring a 100% stake in a Singapore-based firm. Discover the details and market impact here.
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Nivin Pauly's 'Pharma', Malayalam's first medical drama web series, is now streaming. Our review explores its gripping plot, stellar cast, and why it's a binge-worthy thriller. Watch now!
Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.
Malayalam star Nivin Pauly headlines 'Pharma', a hard-hitting web series on the dark side of the pharmaceutical industry. Premieres December 19, 2025, on JioHotstar in 5 languages.
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Odisha CM Mohan Charan Majhi launches the Pharmaceutical and Medical Devices Policy 2025, aiming to attract investments and create jobs. The state announces two dedicated industrial parks. Read more.